Zevra Therapeutics, Inc. (ZVRA)
11.65
-0.22
(-1.85%)
USD |
NASDAQ |
Aug 24, 16:00
11.66
+0.01
(+0.09%)
After-Hours: 20:00
Zevra Therapeutics Market Cap : 691.33M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 691.33M |
| August 21, 2026 | 704.39M |
| August 20, 2026 | 705.58M |
| August 19, 2026 | 719.82M |
| August 18, 2026 | 686.59M |
| August 17, 2026 | 684.21M |
| August 14, 2026 | 671.75M |
| August 13, 2026 | 663.44M |
| August 12, 2026 | 678.87M |
| August 11, 2026 | 672.94M |
| August 10, 2026 | 681.24M |
| August 07, 2026 | 685.99M |
| August 06, 2026 | 704.98M |
| August 05, 2026 | 624.87M |
| August 04, 2026 | 624.28M |
| August 03, 2026 | 596.68M |
| July 31, 2026 | 562.18M |
| July 30, 2026 | 569.87M |
| July 29, 2026 | 578.14M |
| July 28, 2026 | 575.19M |
| July 27, 2026 | 574.00M |
| July 24, 2026 | 563.07M |
| July 23, 2026 | 740.12M |
| July 22, 2026 | 717.65M |
| July 21, 2026 | 735.98M |
| Date | Value |
|---|---|
| July 20, 2026 | 711.15M |
| July 17, 2026 | 754.90M |
| July 16, 2026 | 754.30M |
| July 15, 2026 | 766.13M |
| July 14, 2026 | 772.04M |
| July 13, 2026 | 779.13M |
| July 10, 2026 | 789.18M |
| July 09, 2026 | 824.06M |
| July 08, 2026 | 871.94M |
| July 07, 2026 | 853.62M |
| July 06, 2026 | 825.83M |
| July 02, 2026 | 826.42M |
| July 01, 2026 | 816.38M |
| June 30, 2026 | 847.71M |
| June 29, 2026 | 828.20M |
| June 26, 2026 | 799.23M |
| June 25, 2026 | 782.09M |
| June 24, 2026 | 773.22M |
| June 23, 2026 | 768.49M |
| June 22, 2026 | 747.80M |
| June 18, 2026 | 762.58M |
| June 17, 2026 | 745.44M |
| June 16, 2026 | 747.80M |
| June 15, 2026 | 741.89M |
| June 12, 2026 | 747.80M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Innoviva, Inc. | 1.528B |
| Collegium Pharmaceutical, Inc. | 888.83M |
| Johnson & Johnson | 657.54B |
| Ligand Pharmaceuticals, Inc. | 5.581B |
| Harrow, Inc. | 1.492B |
Market Cap Related Metrics
| PE Ratio | 12.57 |
| PS Ratio | 5.086 |
| Price to Book Value | 3.176 |
| Price to Free Cash Flow | 21.21 |
| Price | 11.65 |
| Earnings Yield | 7.96% |
| Operating PE Ratio | 17.71 |
| Normalized PE Ratio | 10.27 |